FAKTOR-OPTIONSSCHEIN - ORION B | Market Closed - Börse Stuttgart 02:15:52 2024-07-12 pm EDT | ||
| 15.17 EUR | 0.00% |
|
| 1 month | +34.24% | ||
| 3 months | +85.19% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ORION OYJ
Latest news about ORION OYJ
More news
| Date | Price | Change |
|---|---|---|
| 24-07-12 | 15.76 | +3.89% |
| 24-07-11 | 15.17 | +1.74% |
| 24-07-10 | 14.91 | -0.60% |
| 24-07-09 | 15 | -3.54% |
| 24-07-08 | 15.55 | -1.33% |
Delayed Quote Börse Stuttgart
Last update July 12, 2024 at 02:15 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | ORION OYJ |
| Issuer | Morgan Stanley |
| WKN | MG1JRE |
| ISIN | DE000MG1JRE2 |
| Date issued | 2024-04-03 |
| Strike | 27.47 € |
| Maturity | Unlimited |
| Parity | 0.9 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.66 € |
|---|---|
| Lowest since issue | 7.68 € |
| Spread | 0.37 € |
| Spread % | 2.41% |
Company Profile
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows:
- generic, OTC and biosimilar drugs (43.4%);
- patented prescription products (41.7%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments;
- animal health products (8.7%);
- pharmaceutical ingredients and outsourcing services (6.2%).
Net sales break down primarily by source of revenue between sales of products (86.9%) and royalties (10.4%).
Net sales are distributed geographically as follows: Finland (28%), Scandinavia (12%), Europe (30.8%), North America (14.7%) and other (14.5%).
Sector
-
Consensus: Orion Oyj
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
41.12
EUR
Average target price
38.6
EUR
Spread / Average Target
-6.13%
- Stock Market
- Certificates
- Certificat
